GRI

Commission Implementing Regulation (EU) 2025/910 of 20 May 2025 concerning the non-renewal of the approval of the active substance flufenacet, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulations (EU) No 540/2011 and (EU) 2015/408

Bill Product Regulation & Liability PUBLISHED
Date: 21st May, 2025 Source: Register of Delegated and Implementing Acts Country: European Union Original Source

Brief

The Commission Implementing Regulation (EU) 2024/2563 has amended Implementing Regulation (EU) 2022/1646 to update requirements for national risk-based control plans and surveillance plans in EU Member States. The changes aim to improve data consistency, transparency, and enforcement of pharmacologically active substances regulations, with a minimum sampling frequency adjusted for certain substance groups, effective from January 1, 2025.

This content is restricted.

Highlights content goes here...

This content is restricted.

Register of Delegated and Implementing Acts

Quick Insight
RADA.AI
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested
Related Documents
Administrative Review Tribunal and Other Legislation Amendment Bill 2025
Date: 3rd Sep, 2025 Source: Parliament of Australia Country: Australia
Bill Human rights nan
Pacific Banking Guarantee Bill 2025B
Date: 24th Jul, 2025 Source: Parliament of Australia Country: Australia
Bill Financial services nan
PL 3144/2025
Date: 1st Jul, 2025 Source: Chamber of Deputies Country: Brazil
Bill Competition nan

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Click here

Enter your Email

Enter your registered username/email id.

Enter your Email

Enter your email id below to signup.
Individual Plan
  • Designed for Growing Compliance Teams
$125 / month OR $1250 / year
Features
  • • Coverage for 20 jurisdictions
  • • Monitoring from 500+ regulatory authorities
  • • AI compliance summaries
  • • RaDa.ai : Single-Role
Best for: Researchers, Legal professionals, Academics
Subscribe Now
Enterprise Plan
  • Perfect for Global Enterprises
Contact for Pricing
Features
  • • Custom jurisdictional coverage
  • • Custom monitoring of regulatory authorities
  • • RaDa.ai : Customizable multi-role
  • • Custom reporting and dashboard capabilities
  • • API access for seamless integration
Best for: Law Firms, Corporations, Government Bodies
Contact Sales